138 related articles for article (PubMed ID: 35966938)
1. Immunohistochemical Features of Breast Cancer Seen in Women in Kinshasa, Democratic Republic of the Congo: A Six-Year Retrospective Study.
Maseb'a Mwang Sulu S; Batalansi DB; Sulu AMS; Mukuku O; Mboloko JE; Mashinda DK; Massamba BL; Tshimpi AW
Int J Breast Cancer; 2022; 2022():8860947. PubMed ID: 35966938
[TBL] [Abstract][Full Text] [Related]
2. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.
Elidrissi Errahhali M; Elidrissi Errahhali M; Ouarzane M; El Harroudi T; Afqir S; Bellaoui M
BMC Womens Health; 2017 Jan; 17(1):3. PubMed ID: 28068979
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification of breast cancer: A retrospective cohort study.
Al-Thoubaity FK
Ann Med Surg (Lond); 2020 Jan; 49():44-48. PubMed ID: 31890196
[TBL] [Abstract][Full Text] [Related]
4. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
5. Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size.
Rahmawati Y; Setyawati Y; Widodo I; Ghozali A; Purnomosari D
Asian Pac J Cancer Prev; 2018 Jan; 19(1):161-166. PubMed ID: 29373908
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Clinicopathological Features and Molecular Markers in Bahraini Women With Breast Cancer.
AlZaman A; Ali E; Mohamad B; Islam M; AlZaman E; AlZaman Y
Gulf J Oncolog; 2020 Jan; 1(32):19-25. PubMed ID: 32342914
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
8. Invasive breast cancer: a significant correlation between histological types and molecular subgroups.
Caldarella A; Buzzoni C; Crocetti E; Bianchi S; Vezzosi V; Apicella P; Biancalani M; Giannini A; Urso C; Zolfanelli F; Paci E
J Cancer Res Clin Oncol; 2013 Apr; 139(4):617-23. PubMed ID: 23269487
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study.
Alnegheimish NA; Alshatwi RA; Alhefdhi RM; Arafah MM; AlRikabi AC; Husain S
Saudi Med J; 2016 May; 37(5):506-12. PubMed ID: 27146612
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer in togolese women: immunohistochemistry subtypes.
Adani-Ifè A; Amégbor K; Doh K; Darré T
BMC Womens Health; 2020 Nov; 20(1):261. PubMed ID: 33228656
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer molecular subtype and relationship with clinicopathological profiles among Vietnamese women: A retrospective study.
Thuc Nguyen TM; Dinh Le R; Nguyen CV
Pathol Res Pract; 2023 Oct; 250():154819. PubMed ID: 37748212
[TBL] [Abstract][Full Text] [Related]
12. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women.
Rweyemamu LP; Akan G; Adolf IC; Magorosa EP; Mosha IJ; Dharsee N; Namkinga LA; Lyantagaye SL; Nateri AS; Atalar F
BMC Womens Health; 2021 Dec; 21(1):423. PubMed ID: 34930226
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer molecular subtypes in oman: correlation with age, histology, and stage distribution - analysis of 542 cases.
Mehdi I; Monem AA; Al Bahrani B; Ramadhan FA
Gulf J Oncolog; 2014 Jan; 1(15):38-48. PubMed ID: 24610287
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of indonesian breast cancers with different molecular subtypes.
Widodo I; Dwianingsih EK; Triningsih E; Utoro T; Soeripto
Asian Pac J Cancer Prev; 2014; 15(15):6109-13. PubMed ID: 25124582
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in Angola, molecular subtypes: a first glance.
Miguel F; Lopes LV; Ferreira E; Ribas E; Pelaez AF; Leal C; Amaro T; Lopes P; Santos CM; Lopes C; Santos LL
Ecancermedicalscience; 2017; 11():763. PubMed ID: 28900476
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prolactin receptor expression in breast cancer subtypes].
Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
[TBL] [Abstract][Full Text] [Related]
17. Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features.
Akbar M; Akbar K; Naveed D
J Ayub Med Coll Abbottabad; 2014; 26(3):290-3. PubMed ID: 25671929
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study.
Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K
Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors.
Sohn YM; Han K; Seo M
Iran J Radiol; 2016 Oct; 13(4):e31386. PubMed ID: 27895868
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease.
Naleskina LA; Lukianova NY; Sobchenko SO; Storchai DM; Chekhun VF
Exp Oncol; 2016 Sep; 38(3):181-6. PubMed ID: 27685526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
